Iterum Therapeutics PLC
(NASDAQ:ITRM)
$1.47
0.07[5.00%]
Last update: 1:39PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics Stock (NASDAQ:ITRM), Quotes and News Summary

Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.

Loading...
Day Range1.420 - 1.47052 Wk Range0.220 - 7.050Open / Close1.450 / -Float / Outstanding12.069M / 12.233M
Vol / Avg.95.554K / 361.629KMkt Cap17.983MP/E-50d Avg. Price1.140
Div / Yield (Forward)- / -%Payout Ratio-Total Float12.069MEPS-3.220
Vandana Singh - Jul 11, 2022, 2:31PM
Globe Newswire - Oct 17, 2022, 5:19PM
Globe Newswire - May 11, 2022, 8:00AM
InvestorPlace - Jul 11, 2022, 11:46AM
InvestorPlace - Jul 11, 2022, 11:14AM
Seeking Alpha - Mar 28, 2022, 7:02AM
InvestorsObserver - Feb 25, 2022, 8:50AM
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-27
REV
Q3 2022Est.ActualSurprise
EPS-1.050-0.430 0.6200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.